UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2018

 

or

 

☐   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File Number: 0-11102

 

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in its charter)

 

Florida   59-1564329

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

4041 SW 47 Avenue, Fort Lauderdale, Florida   33314
(Address of principal executive offices)   (Zip Code)

 

954-587-6280

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer     Accelerated filer  ☐ 
 Non-accelerated filer   ☐ (Do not check if a smaller reporting company)   Smaller reporting company ☒ 
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐    No ☒

 

At August 13, 2018, 9,258,580 shares of the registrant’s Common Stock were outstanding.

 

 

 

 

 

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

    Page
PART I Financial Information:  
     
Item 1. Financial Statements 1
     
  Condensed consolidated balance sheets at June 30, 2018 (unaudited) and December 31, 2017 1
     
  Condensed consolidated statements of operations (unaudited) for the three and six months ended June 30, 2018 and 2017 2
     
  Condensed consolidated statements of comprehensive income  (unaudited) for the three and six months ended June 30, 2018 and 2017 3
     
  Condensed consolidated statements of cash flows (unaudited) for the six months ended June 30, 2018 and 2017 4
     
  Notes to condensed consolidated financial statements 5-13
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14-18
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 19
     
Item 4. Controls and Procedures 19
     
PART II Other Information:  
     
Item 1A. Risk Factors 19
     
Item 6. Exhibits 20
     
  Signatures 21

  

 

 

 

PART 1 - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   June 30,
2018
   December 31,
2017
 
   (Unaudited)     
ASSETS        
Current Assets:        
Cash  $922,985   $2,418,484 
Trade accounts receivable less allowances of approximately $152,000 and $79,000, respectively   9,071,740    4,963,895 
Receivables due from affiliated companies   887,681    1,584,365 
Restricted cash   2,765,346    2,747,360 
Inventories, net   10,133,830    9,074,426 
Prepaid expenses and other current assets   1,118,583    1,013,213 
Total Current Assets   24,900,165    21,801,743 
           
Property, plant and equipment, net   9,730,198    9,291,667 
Intangible assets, net   862,268    897,408 
Total Assets  $35,492,631   $31,990,818 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current Liabilities:          
Current portion of long-term debt, net  $242,344   $240,017 
Revolving line of credit   1,100,000    --- 
Accounts payable - trade   2,545,561    1,807,120 
Accrued expenses payable   1,369,855    812,062 
Total Current Liabilities   5,257,760    2,859,199 
           
Deferred tax liability   280,813    153,895 
Long-term debt, less current portion and debt issuance costs   3,958,645    4,081,793 
Total Liabilities   9,497,218    7,094,887 
           
Commitments and contingencies (Note 9)          
Shareholders’ Equity:          
Common stock - $.01 par value, 12,000,000 shares authorized; 9,258,580 and 9,254,580 shares issued and outstanding   92,586    92,546 
Additional paid in capital   9,945,464    9,931,634 
Accumulated other comprehensive loss   (291,895)   (288,051)
Retained earnings   16,249,258    15,159,802 
Total Shareholders’ Equity   25,995,413    24,895,931 
           
Total Liabilities and Shareholders’ Equity  $35,492,631   $31,990,818 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 1 

 

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2018   2017   2018   2017 
                 
Net sales  $11,398,539   $9,622,442   $19,782,752   $17,842,996 
                     
Cost of goods sold   6,744,504    5,565,852    12,150,621    10,809,695 
                     
Gross profit   4,654,035    4,056,590    7,632,131    7,033,301 
                     
Operating Expenses:                    
Advertising and promotion   893,744    672,335    1,645,144    1,362,687 
Selling and administrative   2,289,070    1,983,838    3,843,847    3,527,861 
Total operating expenses   3,182,814    2,656,173    5,488,991    4,890,548 
                     
Operating income   1,471,221    1,400,417    2,143,140    2,142,753 
                     
Other expense                    
Interest, net (expense)   (33,670)   (942)   (26,284)   (2,890)
                     
Income before income taxes   1,437,551    1,399,475    2,116,856    2,139,863 
                     
Provision for income taxes   (316,200)   (446,963)   (472,125)   (683,427)
                     
Net income  $1,121,351   $952,512   $1,644,731   $1,456,436 
                     
Earnings per common share – basic and diluted  $0.12   $0.10   $0.18   $0.16 
                     
Dividends declared per common share  $0.00   $0.06   $0.06   $0.06 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 2 

 

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2018   2017   2018   2017 
                 
Net Income  $1,121,351   $952,512   $1,644,731   $1,456,436 
Foreign currency translation adjustment   (378)   759    (3,844)   (800)
                     
Comprehensive income  $1,120,973   $953,271   $1,640,887   $1,455,636 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 3 

 

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

 

   Six Months Ended 
   June 30, 
   2018   2017 
Cash flows from operating activities:        
         
Net income  $1,644,731   $1,456,436 
Adjustments to reconcile net income to net cash (used in) provided by operating activities:          
           
Depreciation and amortization   522,513    487,442 
Deferred income taxes   126,918    30,019 
Stock based compensation   13,870    17,360 
Provision for bad debts   74,872    26,801 
Other operating non-cash items   246    4,612 
           
Changes in assets and liabilities:          
           
Trade accounts receivable   (4,182,717)   (1,336,219)
Receivables due from affiliated companies   696,684    (120,743)
Inventories   (1,063,096)   (1,614,440)
Prepaid expenses and other current assets   (105,370)   281,382 
Accounts payable – trade   738,441    717,835 
Income taxes payable   ---    25,108 
Accrued expenses payable   557,793    142,422 
Net cash (used in) provided by operating activities   (975,115)   118,015 
           
Cash flows from investing activities:          
Purchases of property, plant and equipment   (916,096)   (2,533,577)
Net cash used in investing activities   (916,096)   (2,533,577)
           
Cash flows from financing activities:          
Payments on long-term debt   (130,629)   (231,505)
Borrowings on revolving line of credit   1,100,000    --- 
Dividends paid to common shareholders   (555,275)   (549,255)
Net cash provided by (used in) financing activities   414,096    (780,760)
           
Effect of exchange rate on cash   (398)   (6,053)
           
Net decrease in cash and restricted cash   (1,477,513)   (3,202,375)
           
Cash and restricted cash at beginning of period   5,165,844    4,070,445 
Cash and restricted cash at end of period  $3,688,331   $868,070 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest during period  $35,987   $3,546 
Cash paid for income taxes during period  $364,000   $628,300 
           
Cash  $922,985   $868,070 
Restricted cash   2,765,346    --- 
Total cash and restricted cash  $3,688,331   $868,070 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 4 

 

 

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1.SUMMARY OF ACCOUNTING POLICIES

 

Interim reporting

 

The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain prior period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries.

 

The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

 

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018.

 

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

 

Use of estimates

 

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions.

 

2.RECENT ACCOUNTING PRONOUNCEMENTS

 

Accounting Guidance Adopted by the Company

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09, which has been modified on several occasions, provides new guidance designed to enhance the comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets. The core principle of the new guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new guidance also requires disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the new guidance effective January 1, 2018, using the full retrospective method, under which the Company applies the new guidance to each comparative period presented. Under the new guidance, the Company’s performance obligation to its customers under agreements currently in force is satisfied when the goods are shipped or picked up by the customer and title of the goods is transferred (generally upon such shipment or pick up); with regard to a customer for which the Company’s inventory is held at the customer’s warehouses, the Company’s performance obligation is deemed satisfied when the Company is notified of sales by the customer. While the timing of the Company’s revenue recognition did not change, certain allowances provided by the Company to customers, primarily for cooperative advertising, are now considered a reduction of net sales instead of an advertising and promotion expense. This reclassification did not affect net income.

 

 5 

 

 

In November 2016, the FASB issued ASU 2016-18, which requires that a statement of cash flows explain the change during the reporting period in the total of cash, cash equivalents, and amounts generally described as restricted cash and restricted cash equivalents. The new guidance also requires disclosure of such amounts in the statements of cash flows or in the financial statement footnotes if restricted cash and restricted cash equivalents are presented in separate line items in the balance sheet. The Company adopted this guidance effective January 1, 2018. In accordance with the new guidance, the Company includes additional disclosures regarding its cash and restricted cash amounts in its statement of cash flows for each comparative period presented.

 

Accounting Guidance Not Yet Adopted by the Company

 

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” Under this new guidance, lessees (including lessees under leases classified as finance leases, which are to be classified based on criteria similar to that applicable to capital leases under current guidance, and leases classified as operating leases) will recognize a right-to-use asset and a lease liability on the balance sheet, initially measured as the present value of lease payments under the lease. Under current guidance, operating leases are not recognized on the balance sheet. The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements; the guidance provides certain practical expedients. The Company is currently evaluating this guidance to determine its impact on the Company’s financial statements.

 

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles-Goodwill and Other,” which simplifies the quantitative test for goodwill impairment. Under current guidance, if a reporting unit’s carrying value exceeds its fair value, the entity must determine the implied value of goodwill. This determination is made by deducting the fair value of a reporting unit’s identifiable assets and liabilities from the fair value of the reporting unit as a whole as if the reporting unit had just been acquired. Under the new guidance, a determination of the implied value of goodwill will no longer be required; a goodwill impairment will be equal to the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The guidance is effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this new standard will have on the Company’s financial statements.

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses,” which replaces the “incurred loss” model under current GAAP with a forward-looking “expected loss” model, principally in connection with financial assets subject to credit losses. Under current GAAP, an entity reflects credit losses on financial assets measured on an amortized cost basis only when it is probable that losses have been incurred, generally considering only past events and current conditions in making these determinations. The guidance under ASU 2016-13 prospectively replaces this approach with a forward-looking methodology that reflects the expected credit losses over the lives of financial assets, beginning when such assets are first acquired. Under the expected loss model, credit losses will be measured based not only on past events and current conditions, but also on reasonable and supportable forecasts that affect the collectability of financial assets. The guidance also expands disclosure requirements. The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted as of January 1, 2019. The Company is currently evaluating the impact the adoption of this new standard will have on the Company’s financial statements. 

 

 6 

 

 

3.INVENTORIES

 

The Company’s inventories at June 30, 2018 and December 31, 2017 consisted of the following:

 

   June 30,
2018
   December 31,
2017
 
Raw materials  $4,546,710   $3,994,624 
Finished goods   5,865,107    5,354,097 
Inventories, gross   10,411,817    9,348,721 
           
Inventory reserves   (277,987)   (274,295)
           
Inventories, net  $10,133,830   $9,074,426 

 

The inventory reserves shown in the table above reflect slow moving and obsolete inventory.

 

The Company operates a vendor managed inventory program with one of its customers to improve the promotion of the Company’s products.  Under the program, Company inventory is held at the customer’s warehouses. The Company manages the inventory levels at the warehouses and recognizes revenue as the products are sold by the customer. The inventories managed at the customer’s warehouses, which are included in inventories, net, amounted to approximately $484,000 and $494,000 at June 30, 2018 and December 31, 2017, respectively.

 

4.PROPERTY, PLANT & EQUIPMENT

 

The Company’s property, plant and equipment at June 30, 2018 and December 31, 2017 consisted of the following:

 

   Estimated
Useful Life
  June 30,
2018
   December 31,
2017
 
            
Land     $278,325   $278,325 
Building and Improvements  30 years   9,315,217    4,673,409 
Manufacturing and warehouse equipment  6-20 years   10,257,069    9,616,086 
Office equipment and furniture  3-5 years   1,770,757    1,367,244 
Leasehold improvements  10-15 years   571,483    567,898 
Vehicles  3 years   10,020    10,020 
Construction in process      428,891    5,197,780 
 Property, plant and equipment, gross      22,631,762    21,710,762 
              
Less accumulated depreciation      (12,901,564)   (12,419,095)
              
Property, plant and equipment, net     $9,730,198   $9,291,667 

 

Construction in progress at June 30, 2018 and December 31, 2017 includes $350,202 and $5,087,897, respectively, relating to the expansion of the manufacturing, warehouse and distribution facilities of the Company’s wholly-owned subsidiary, KINPAK Inc. (“Kinpak”), in Montgomery, Alabama. Depreciation expense totaled $261,055 (of which $219,516 is included in cost of goods sold and $41,539 is included in selling and administrative expenses) and $223,275 (of which $174,022 is included in cost of goods sold and $49,253 is included in selling and administrative expenses) for the three months ended June 30, 2018 and 2017, respectively. Depreciation expense totaled $482,469 (of which $397,171 is included in cost of goods sold and $85,298 is included in selling and administrative expenses) and $452,301 (of which $353,370 is included in cost of goods sold and $98,931 is included in selling and administrative expenses) for the six months ended June 30, 2018 and 2017, respectively.

 

 7 

 

 

5.INTANGIBLE ASSETS

 

The Company’s intangible assets at June 30, 2018 and December 31, 2017 consisted of the following:

 

June 30, 2018 

 

Intangible Asset  Cost   Accumulated
Amortization
   Net 
Patents  $622,733   $413,804   $208,929 
Trade names and trademarks   1,131,125    549,561    581,564 
Royalty rights   160,000    88,225    71,775 
Total intangible assets  $1,913,858   $1,051,590   $862,268 

 

December 31, 2017 

 

Intangible Asset  Cost   Accumulated
Amortization
   Net 
Patents  $622,733   $387,636   $235,097 
Trade names and trademarks   1,131,125    549,561    581,564 
Royalty rights   160,000    79,253    80,747 
Total intangible assets  $1,913,858   $1,016,450   $897,408 

 

At June 30, 2018 and December 31, 2017, the trade names and trademarks are considered indefinite-lived. The patents (the most significant of which (the “ClO2 Patents”) relate to a device for producing chlorine dioxide (ClO2) that is incorporated into the Company’s disinfectant, sanitizer and deodorizer products) had a carrying value, net of amortization, of $208,929 at June 30, 2018 (of which $205,791 is attributable to the ClO2 Patents). The ClO2 Patents expire in 2022 and the other patents expire in 2021. The royalty rights (which the Company purchased from an unaffiliated entity that previously owned the ClO2 Patents and retained the royalty rights after selling the patents) expire in December 2021 and are amortized on a straight line basis over their remaining useful lives.

 

Amortization expense related to intangible assets was $17,570 ($13,084 attributable to the patents and $4,486 attributable to the royalty rights) for each of the three months ended June 30, 2018 and 2017, and $35,140 ($26,168 attributable to the patents and $8,972 attributable to the royalty rights) for each of the six months ended June 30, 2018 and 2017.

 

 8 

 

 

6.REVOLVING LINE OF CREDIT

 

On August 31, 2017, the Company and Regions Bank entered into a Business Loan Agreement (the “Business Loan Agreement”), under which the Company was provided a revolving line of credit. Under the Business Loan Agreement, the Company may borrow up to the lesser of (i) $6,000,000 or (ii) a borrowing base equal to 85% of Eligible Accounts (as defined in the Business Loan Agreement) plus 50% of Eligible Inventory (as defined in the Business Loan Agreement). Interest on amounts borrowed under the revolving line of credit is payable monthly at the one month LIBOR rate plus 1.5% per annum, computed on a 365/360 basis. Eligible Accounts do not include, among other things, accounts receivable from affiliated entities.

 

Outstanding amounts under the revolving line of credit are payable on demand. If no demand is made, the Company may repay and reborrow funds from time to time until expiration of the revolving line of credit on August 31, 2018, at which time all outstanding principal and interest will be due and payable. The Company’s obligations under the revolving line of credit are secured by, among other things, the Company’s accounts receivable and inventory. The Business Loan Agreement includes financial covenants requiring that the Company maintain a minimum fixed charge coverage ratio (generally, the ratio of (A) EBITDA for the most recently completed four fiscal quarters minus the sum of the Company’s distributions to its shareholders, taxes paid and unfunded capital expenditures during such period to (B) current maturities of Company long term debt as of the end of the most recent fiscal quarter plus scheduled interest expense incurred over the most recently completed four fiscal quarters) of 1.20 to 1, tested quarterly, and a maximum “debt to cap” ratio (generally, funded debt divided by the sum of net worth and funded debt) of 0.75 to 1, as of the end of each fiscal quarter. For purposes of computing the fixed charge coverage ratio, “EBITDA” generally is defined as net income before taxes and depreciation expense plus amortization expense, plus interest expense, plus non-recurring and/or non-cash losses and expenses, minus non-recurring and/or non-cash gains and income; “unfunded capital expenditures” generally is defined as capital expenditures made from Company funds other than funds borrowed through term debt incurred to finance such capital expenditures; and “long term debt” generally is defined as “debt instruments with a maturity principal due date of one year or more in length,” including, among other listed contractual debt instruments, “revolving lines of credit” and “capital leases obligations.” At June 30, 2018, the Company was in compliance with these financial covenants. The revolving line of credit is subject to several events of default, including a decline in the majority shareholder’s ownership below 50% of all outstanding shares. At June 30, 2018 and December 31, 2017, the Company had $1,100,000 and $0 borrowings, respectively, under the revolving line of credit provided by the Business Loan Agreement.

 

The Business Loan Agreement terminates on August 31, 2018. The Company is engaged in negotiations with its principal lending bank regarding its revolving credit facility, and expects to enter into an agreement with the bank for a renewal or replacement of its existing facility. However, the Company cannot assure that its negotiations will be successful.

 

7.LONG TERM DEBT

 

Industrial Development Bond Financing

 

On September 26, 2017, Kinpak indirectly obtained a $4,500,000 loan from Regions Capital Advantage, Inc. (the “Lender”). The proceeds of the loan are being used principally to pay or reimburse costs of constructing an approximately 85,000 square foot addition to Kinpak’s manufacturing, warehouse and distribution facilities in Montgomery, Alabama, and costs of purchasing and installing associated machinery and equipment (the “Project”).

 

The loan was funded by the Lender’s purchase of a $4,500,000 industrial development bond (the “Bond”) issued by The Industrial Development Board of the City of Montgomery, Alabama (the “IDB”). The Bond is a limited obligation of the IDB and is payable solely out of revenues and receipts derived from the leasing or sale of Kinpak’s facilities. In this regard, Kinpak is obligated to fund the IDB’s payment obligations by providing rental payments under a lease between the IDB and Kinpak (the “Lease”), under which Kinpak leases its facilities from the IDB. Under the Lease, prior to the maturity date of the Bond, Kinpak may repurchase the facilities for $1,000 if the Bond has been redeemed or fully paid.

 

The Bond bears interest at the rate of 3.07% per annum, calculated on the basis of a 360-day year and the actual number of days elapsed (subject to increase to 6.07% per annum upon the occurrence of an event of default), and is payable in 118 monthly installments of $31,324 beginning on November 1, 2017 and ending on August 1, 2027, with a final principal and interest payment to be made on September 1, 2027 in the amount of $1,799,201. The Bond provides that the interest rate will be subject to adjustment if it is determined by the United States Treasury Department, the Internal Revenue Service, or a similar government entity that the interest on the Bond is includable in the gross income of the Lender for federal income tax purposes.

 

 9 

 

 

Under the Lease, Kinpak is required to make rental payments for the account of the IDB to the Lender in such amounts and at such times as are necessary to enable the payment of all principal and interest due on the Bond and other charges, if any, payable in respect of the Bond. The Lease also provides that Kinpak may redeem the Bond, in whole or in part, by prepaying its rental payment obligations in an amount sufficient to effect the redemption. In addition, the Lease contains provisions relating to the Project, including limitations on utilization of Bond proceeds, deposit of unused proceeds into a custodial account (as described below) and investment of monies held in the custodial account.

 

Payment of amounts due and payable under the Bond and other related agreements are guaranteed by the Company and its other consolidated subsidiaries. In connection with its guarantee, the Company is subject to certain covenants, including financial covenants that effectively are substantially the same as the financial covenants included in the Business Loan Agreement described in Note 6.

 

Through June 30, 2018, of the $4,500,000 proceeds of the Bond sale, approximately $1,704,000 has been applied to reimburse Kinpak for Project expenditures and approximately $54,000 was paid directly to other parties for certain transaction costs. The remaining amount is held in a custodial account and may be drawn by Kinpak from time to time to fund additional expenditures related to the Project. Because the Lease contains limitations on the manner in which Kinpak may utilize funds held in the custodial account, such funds are classified as restricted cash on the Company’s balance sheets.

 

The Company incurred debt issuance costs of $196,095 in connection with the financing. These costs are shown as a reduction of the debt balance and are being amortized in accordance with the effective interest method.

 

Capital Lease Obligations

 

At June 30, 2018 and December 31, 2017, the Company was obligated under capital lease agreements covering equipment utilized in the Company’s operations.  The capital leases, aggregating approximately $39,000 and $50,000 at June 30, 2018 and December 31, 2017, respectively, mature on July 1, 2020 and carry an interest rate of 2%.

 

The following table provides information regarding the Company’s long-term debt at June 30, 2018 and December 31, 2017:

 

   Current Portion   Long Term Portion 
   June 30,
2018
   December 31,
2017
   June 30,
2018
   December 31,
2017
 
Obligations related to industrial development bond financing  $244,150   $240,395   $4,099,036   $4,222,241 
Capitalized equipment leases   17,810    19,238    21,437    31,188 
Total principal of long term debt   261,960    259,633    4,120,473    4,253,429 
Debt issuance costs   (19,616)   (19,616)   (161,828)   (171,636)
Total long term debt  $242,344   $240,017   $3,958,645   $4,081,793 

 

Required principal payments under the Company’s long term obligations are set forth below:

 

Twelve month period ending June 30,    
2019  $261,960 
2020   271,294 
2021   261,464 
2022   268,003 
2023   276,465 
Thereafter   3,043,247 
Total  $4,382,433 

 

 10 

 

 

8.RELATED PARTY TRANSACTIONS

 

During the three and six months ended June 30, 2018 and 2017, the Company sold products to companies affiliated with Peter G. Dornau, who is the Company’s Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $369,000 and $539,000 during the three months ended June 30, 2018 and 2017, respectively, and approximately $1,189,000 and $1,286,000 for the six months ended June 30, 2018 and 2017, respectively. Fees for administrative services aggregated approximately $251,000 and $260,000 (including approximately $24,000 and $28,000, respectively, to reimburse the Company for business related expenditures that it made on behalf of the affiliated companies) during the three months ended June 30, 2018 and 2017, respectively.  Fees for administrative services aggregated approximately $429,000 for each of the six month periods ended June 30, 2018 and 2017 (including approximately $53,000 and $49,000, respectively, to reimburse the Company for business related expenditures that it made on behalf of the affiliated companies).  The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $888,000 and $1,584,000 at June 30, 2018 and December 31, 2017, respectively.

 

An entity that is owned by the Company’s Chairman, President and Chief Executive Officer provides several services to the Company.  Under this arrangement, the Company paid the entity $10,500 for research and development services for each of the three month periods ended June 30, 2018 and 2017, and $21,000 for such services during each of the six month periods ended June 30, 2018 and 2017. The research and development expenses are included in the statements of operations for the three and six months ended June 30, 2018 and 2017 as a selling and administrative expense. In addition, during the three months ended June 30, 2018 and 2017, the Company paid this entity $6,000 and $0, respectively, for providing charter boat services for marketing and entertainment of Company customers, and $10,500 and $45,000 for such services during the six months ended June 30, 2018 and 2017. The charter boat services are included in the statements of operations for the three and six months ended June 30, 2018 and 2017 as an advertising and promotion expense. During the three and six months ended June 30, 2018, the Company also paid this entity $21,000 for the production of television commercials, which will be expensed over a twelve month period ending on March 31, 2019.

 

The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.  See Note 9 for a description of the lease terms.

 

A director of the Company is Regional Executive Vice President of an insurance broker through which the Company sources most of its insurance needs.  During the three months ended June 30, 2018 and 2017, the Company paid an aggregate of approximately $261,000 and $244,000, respectively, and during the six months ended June 30, 2018 and 2017, the Company paid an aggregate of approximately $449,000 and $439,000, respectively, in insurance premiums on policies obtained through the insurance broker.

 

9.COMMITMENTS AND CONTINGENCIES

 

The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by Peter G. Dornau, the Company’s Chairman, President and Chief Executive Officer. The lease, as extended, expires on December 31, 2023. The lease requires an annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into a previous lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party.  Rent expense under the lease was approximately $25,000 for each of the three months ended June 30, 2018 and 2017 and was approximately $49,000 for each of the six months ended June 30, 2018 and 2017.

 

The Company also leased a 15,000 square foot warehouse in Montgomery, AL near its Kinpak manufacturing facility for the purpose of fabricating and assembling brushes used for cleaning boats, automobiles, and recreational vehicles. The Company paid monthly rent of $4,375 under the lease, which commenced on August 1, 2016 and expired on July 31, 2018. The Company has relocated the brush fabrication and assembly operations from the leased warehouse to Kinpak’s facilities, which are being expanded in connection with the Project. See Note 7 above.

 

 11 

 

 

10.EARNINGS PER SHARE

 

Basic earnings per share are calculated by dividing net income by the weighted average number of shares outstanding during the reporting period.  Diluted earnings per share reflect additional dilution from potential common stock issuances upon the exercise of outstanding stock options.  The following table sets forth the computation of basic and diluted earnings per common share, as well as a reconciliation of the weighted average number of common shares outstanding to the weighted average number of shares outstanding on a diluted basis.

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2018   2017   2018   2017 
Earnings per common share – Basic                
                 
Net income  $1,121,351   $952,512   $1,644,731   $1,456,436 
                     
Weighted average number of common shares outstanding   9,256,206    9,154,768    9,255,398    9,150,874 
                     
Earnings per common share – Basic  $0.12   $0.10   $0.18   $0.16 
                     
Earnings per common share – Diluted                    
                     
Net income  $1,121,351   $952,512   $1,644,731   $1,456,436 
                     
Weighted average number of common shares outstanding   9,256,206    9,154,768    9,255,398    9,150,874 
                     
Dilutive effect of employee stock-based awards   40,483    66,807    41,638    69,097 
                     
Weighted average number of common shares outstanding - Diluted   9,296,689    9,221,575    9,297,036    9,219,971 
                     
Earnings per common share – Diluted  $0.12   $0.10   $0.18   $0.16 

 

The Company had no stock options outstanding during each of the three and six month periods ended June 30, 2018 and 2017, respectively, that were antidilutive and therefore not included in the diluted earnings per common share calculation.

 

 12 

 

 

11.SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

 

 Stock compensation expense during the three and six months ended June 30, 2018 and 2017 was $13,870 and $17,360, respectively, all of which relates to the shares of Company common stock issued to the Company’s non-employee directors as part of their compensation for service on the Board of Directors. There is no unrecognized compensation expense related to stock options.

 

The following table provides information regarding outstanding stock options, all of which were granted under the Company’s 2008 Non-Qualified Stock Option Plan.

 

Date

Granted

 

Shares

Underlying

Options Outstanding

  

Shares

Underlying Exercisable

Options

  

Exercise

Price

  

Expiration

Date

 

Weighted

Average

Remaining
Term

 
1/11/09   40,000    40,000   $0.69   1/10/19   0.5 
4/26/10   20,000    20,000   $2.07   4/25/20   1.8 
                        
    60,000    60,000   $1.15       1.0 

 

12.CASH DIVIDENDS

 

On March 19, 2018, the Company’s Board of Directors declared a special cash dividend of $0.06 per common share payable on April 16, 2018 to all shareholders of record on April 2, 2018.  There were 9,254,580 shares of common stock outstanding on April 2, 2018; therefore, dividends aggregating $555,275 were paid on April 16, 2018.

 

On April 13, 2017, the Company’s Board of Directors declared a special cash dividend of $0.06 per common share payable on May 11, 2017 to all shareholders of record on April 27, 2017.  There were 9,154,243 shares of common stock outstanding on April 27, 2018; therefore, dividends aggregating $549,255 were paid on May 11, 2017.

 

13.MAJOR CUSTOMERS

 

During the three months ended June 30, 2018 and 2017, the Company’s three largest customers in terms of net sales accounted for approximately 50.5% (26.0%, 14.3%, 10.2%) and 43.6% (20.8%, 12.2%, 10.6%), respectively, of the Company’s net sales, and during the six months ended June 30, 2018 and 2017 these customers accounted for approximately 43.6% (24.3%, 10.8%, 8.5%) and 42.2% (25.3%, 8.0%, 8.9%), respectively, of the Company’s net sales.

 

At June 30, 2018 and December 31, 2017, trade accounts receivable due from the Company’s three largest customers constituted 67.7% (32.6%, 22.1%, 13.0%) and 36.9% (14.0%, 11.5%, 11.4%) of the Company’s outstanding trade accounts receivable. In February 2018, the Company changed payment terms for its largest customer from 30 days to 90 days.

 

14.SUBSEQUENT EVENT

 

Pursuant to an asset acquisition agreement dated July 13, 2018, the Company acquired assets of Snappy Marine, Inc., a Florida corporation that marketed and distributed Snappy Teak – NU®, a cleaning product for teak decks on boats (“Snappy Marine”). The acquired assets consist of, among other things, Snappy Marine’s trademarks, tradenames and other intellectual property used in its business, including trademarks with respect to “Snappy Marine®” and “Snappy Teak – NU®,” specified marketing, sales and distribution contracts. In addition, the Company acquired limited quantities of product inventory and raw materials. The purchase price for the assets set forth in the asset purchase agreement is $1,358,882. The Company paid $345,882 to Snappy Marine at the closing of the transaction and deposited an additional $13,000 in escrow; the escrow amount may be used by the Company to procure registrations with respect to certain intellectual property rights. Any unused escrow amounts generally will be provided to Snappy Marine. In addition, the Company provided to Snappy Marine a promissory note in the amount of $1,000,000, including interest (of the $1,000,000 amount of the note, $930,528 is recorded as principal, and the remaining $69,472, representing an imputed interest rate of 2.87% per annum, will be charged to interest expense over the term of the note). The note is payable in equal installments of $16,667 over a 60 month period commencing on August 1, 2018, with a final payment due and payable on July 1, 2023. If the note is prepaid in full, the entire outstanding balance of the note (including all unpaid amounts allocated to interest over the remaining term of the note) must be paid. Under circumstances set forth in the asset purchase agreement, the Company may be obligated to pay certain customer refunds, price adjustments and warranty claims asserted through January 31, 2019 with regard to teak products sold by Snappy Marine.  The Company may offset such payments against amounts payable under the promissory note, subject to an aggregate maximum offset of $25,000.

  

 13 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-looking Statements:

 

Certain statements contained in this Quarterly Report on Form 10-Q, including without limitation, estimated costs of expansion of facilities operated by our wholly-owned subsidiary, Kinpak Inc. (“Kinpak”), anticipated demand for antifreeze products in the third and fourth quarters of 2018, our ability to provide required capital to support inventory levels, the effect of price increases in raw materials that are petroleum or chemical based or commodity chemicals on our margins, our ability to renew or replace our revolving line of credit facility, and the sufficiency of funds provided through operations and existing sources of financing to satisfy our cash requirements constitute forward-looking statements. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “believe,” “may,” “will,” “expect,” “anticipate,” “intend,” or “could,” including the negative or other variations thereof or comparable terminology, are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those expressed or implied by such forward-looking statements. Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry; reliance on certain key customers; changes in consumer demand for marine, recreational vehicle and automotive products; advertising and promotional efforts; unanticipated difficulties in negotiations relating to a renewal or replacement of our revolving credit agreement; unanticipated litigation developments; exposure to market risks relating to changes in interest rates, foreign currency exchange rates, prices for raw materials that are petroleum or chemical based and other factors addressed in Part I, Item 1A (“Risk Factors”) in our annual report on Form 10-K for the year ended December 31, 2017.

 

Overview:

 

We are engaged in the manufacture, marketing and distribution of a broad line of appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, under the Star brite® and other trademarks within the United States and Canada. In addition, we produce private label formulations of many of our products for various customers and provide custom blending and packaging services for these and other products. We also manufacture, market and distribute a line of products including disinfectants, sanitizers and deodorizers. We sell our products through national retailers and to national and regional distributors. In addition, we sell products to two companies affiliated with Peter G. Dornau, our Chairman, President and Chief Executive Officer; these companies distribute the products outside of the United States and Canada.

 

We are nearing completion of a project involving the expansion of Kinpak’s manufacturing, warehouse and distribution facilities in Montgomery, Alabama. At June 30, 2018, we have spent an aggregate of approximately $5.8 million, and the total cost of the project is estimated to be approximately $6.7 million.

 

Pursuant to an asset acquisition agreement dated July 13, 2018, we acquired assets of Snappy Marine, Inc., a Florida corporation (“Snappy Marine”) that has marketed and distributed Snappy Teak – NU®, a cleaning product for teak decks on boats. The assets include, among other things, specified intellectual property, marketing, sales and distribution contracts, and limited quantities of inventory and raw materials. See Note 14 to the condensed consolidated financial statements included in this report for additional information. For a number of years prior to the transaction, we manufactured and blended components of Snappy Teak – NU® Snappy Marine.

 

Critical accounting estimates:

 

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates” in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2017 for information regarding our critical accounting estimates.

 

Results of Operations:

 

Three Months Ended June 30, 2018 Compared to the Three Months Ended June 30, 2017

 

The following table provides a summary of our financial results for the three months ended June 30, 2018 and 2017:

 

   For The Three Months Ended
June 30,
 
           Percent   Percentage of Net Sales 
   2018   2017   Change   2018   2017 
Net sales  $11,398,539   $9,622,442    18.5%   100.0%   100.0%
Cost of goods sold   6,744,504    5,565,852    21.2%   59.2%   57.8%
Gross profit   4,654,035    4,056,590    14.7%   40.8%   42.2%
Advertising and promotion   893,744    672,335    32.9%   7.8%   7.0%
Selling and administrative   2,289,070    1,983,838    15.4%   20.1%   20.6%
Operating income   1,471,221    1,400,417    5.1%   12.9%   14.6%
Interest, net (expense)   (33,670)   (942)   N/A    0.3%   0.0%
Provision for income taxes   (316,200)   (446,963)   (29.3)%   2.8%   4.6%
Net income  $1,121,351   $952,512    17.7%   9.8%   9.9%

 

 14 

 

 

Net sales for the three months ended June 30, 2018 increased by approximately $1,776,000, or 18.5%, as compared to the three months ended June 30, 2017. The increase in net sales is principally a result of increased sales of Star brite® branded marine products and increased private label sales to large national retailers.

 

Cost of goods sold increased by approximately $1,179,000, or 21.2%, during the three months ended June 30, 2018, as compared to the three months ended June 30, 2017. The increase in cost of goods sold is primarily a result of higher sales volume. To a lesser extent, the increase reflects greater overtime compensation paid to employees in order to accommodate the higher level of sales, as well as other increased manufacturing costs.

 

Gross profit increased by approximately $597,000 for the three months ended June 30, 2018, as compared to the same period in 2017. Gross profit increased due to our higher sales volumes. As a percentage of net sales, gross profit was approximately 40.8% and 42.2% for the three month periods ended June 30, 2018 and 2017, respectively. The decrease in gross profit as a percentage of net sales is principally due to our sales mix which included a greater proportion of lower margin private label sales, and to volume discounts we provided to a large customer based on the volume of the customer’s purchases of Star brite® branded products during the second quarter of 2018. The decrease in gross profit as a percentage of net sales also reflected the factors addressed in the discussion of cost of goods sold above.

 

Advertising and promotion expenses increased by approximately $221,000, or 32.9%, during the three months ended June 30, 2018, as compared to the same period in 2017. The increase is principally a result of increased internet, magazine, and television advertising, as well as greater cooperative advertising with certain customers. As a percentage of net sales, advertising and promotion expenses increased to 7.8% for the three months ended June 30, 2018, from 7.0% for the same period in 2017.

 

Selling and administrative expenses increased by approximately $305,000, or 15.4%, during the three months ending June 30, 2018, as compared to the same period in 2017. The increase in selling and administrative expenses is principally a result of higher employee compensation, higher sales commissions due to increased sales, and an increase in noncash expenses, principally reflecting an increase in deferred tax expense and in depreciation and amortization expense. As a percentage of net sales, selling and administrative expenses decreased to 20.1% for the three months ended June 30, 2018, from 20.6% for the same period in 2017

 

Interest, net (expense) – Interest expense for the three months ended June 30, 2018 increased by approximately $33,000, as compared to the three months ended June 30, 2017. The increase principally results from interest incurred with respect to our obligations under the industrial development bond financing related to the expansion of Kinpak’s manufacturing, warehouse and distribution facilities.

 

Provision for income taxes – Our income tax provision for the three months ended June 30, 2018 was approximately $316,000, or 22.0% of our pretax income, compared to approximately $447,000, or 31.9% of pretax income, for the same period in 2017. The lower 2018 tax rate reflects the reduction of our U.S. corporate income tax rate from 34% to 21% under the Tax Cuts and Jobs Act.

 

Six Months Ended June 30, 2018 Compared to the Six Months Ended June 30, 2017

 

The following table provides a summary of our financial results for the six months ended June 30, 2018 and 2017:

 

   For The Six Months Ended
June 30,
 
           Percent   Percentage of Net Sales 
   2018   2017   Change   2018   2017 
Net sales  $19,782,752   $17,842,996    10.9%   100.0%   100.0%
Cost of goods sold   12,150,621    10,809,695    12.4%   61.4%   60.6%
Gross profit   7,632,131    7,033,301    8.5%   38.6%   39.4%
Advertising and promotion   1,645,144    1,362,687    20.7%   8.3%   7.6%
Selling and administrative   3,843,847    3,527,861    9.0%   19.4%   19.8%
Operating income   

2,143,140

    2,142,753    0.0%   10.8%   12.0%
Interest, net (expense)   (26,284)   (2,890)   809.5%   0.1%   0.0%
Provision for income taxes   (472,125)   (683,427)   (30.9)%   2.4%   3.8%
Net income  $1,644,731   $1,456,436    12.9%   8.3%   8.2%

 

Net sales for the six months ended June 30, 2018 increased by approximately $1,940,000, or 10.9%, as compared to the six months ended June 30, 2017. The increase primarily reflects higher sales of Star brite® branded products and increased private label sales to large national retailers.

 

 15 

 

 

Cost of goods sold increased by approximately $1,341,000, or 12.4%, during the six months ended June 30, 2018 as compared to the same period in 2017.  The increase in cost of goods sold is principally a result of higher sales volume and, to a lesser extent, increased manufacturing costs.

 

Gross profit increased by approximately $599,000, or 8.5%, during the six months ended June 30, 2018 as compared to the same period in 2017. Gross profit increased due to higher sales volume. As a percentage of net sales, gross profit was approximately 38.6% and 39.4% for the six month periods ended June 30, 2018 and 2017, respectively. The change in gross profit percentage during the six months ended June 30, 2018 as compared to the six months ended June 30, 2017 is primarily a result of our sales mix, which included an increased proportion of private label sales.

 

Advertising and promotion expenses increased by approximately $282,000, or 20.7%, during the six months ended June 30, 2018, as compared to the same period in 2017. The increase is principally a result of increased internet, magazine, and television advertising, as well as greater cooperative advertising with certain customers. As a percentage of net sales, advertising and promotion expenses increased to approximately 8.3% for the six months ended June 30, 2018, from 7.6% for the same period in 2017.

 

Selling and administrative expenses increased by approximately $316,000, or 9.0%, during the six months ended June 30, 2018, as compared to the same period in 2017. The increase in selling and administrative expenses is principally a result of higher employee compensation due to increased headcount and higher salaries, higher sales commissions as a result of increased sales, and an increase in noncash expenses, principally reflecting an increase in deferred tax expense and in depreciation and amortization expense. As a percentage of net sales, selling and administrative expenses decreased to 19.4% for the six months ended June 30, 2018, from 19.8% for the same period in 2017. 

 

Interest, net (expense) – Interest expense for the six months ended June 30, 2018 increased by approximately $23,000, as compared to the six months ended June 30, 2017. The increase principally results from interest incurred with respect to our obligations under the industrial development bond financing related to the expansion of Kinpak’s manufacturing, warehouse and distribution facilities.

 

Provision for income taxes – Our income tax provision for the six months ended June 30, 2018 was approximately $472,000, or 22.3% of our pretax income, compared to approximately $683,000, or 31.9% of pretax income, for the same period in 2017. The lower 2018 tax rate reflects the reduction of our U.S. corporate income tax rate from 34% to 21% under the Tax Cuts and Jobs Act.

 

 16 

 

 

Liquidity and capital resources:

 

Our cash balance was approximately $923,000 at June 30, 2018 compared to approximately $2,418,000 at December 31, 2017. In addition, we had restricted cash of approximately $2,765,000 and $2,747,000 at June 30, 2018 and December 31, 2017, respectively. The restricted cash constitutes amounts held in a custodial account that are to be used from time to time to fund additional expenditures in connection with the expansion of Kinpak’s manufacturing, warehouse and distribution facilities. See Note 7 to the condensed consolidated financial statements included in this report for additional information.

 

The following table summarizes our cash flows for the six months ended June 30, 2018 and 2017:

 

  

Six Months Ended

June 30,

 
   2018   2017 
Net cash (used in) provided by operating activities  $(975,115)  $118,015 
Net cash used in investing activities   (916,096)   (2.533,577)
Net cash provided by (used in) financing activities   414,096    (780,760)
Effect of exchange rate fluctuations on cash   (398)   (6,053)
Net decrease in cash and restricted cash  $(1,477,513)  $(3,202,375)

 

Net cash used by operating activities for the six months ended June 30, 2018 was approximately $975,000, as compared to net cash provided by operating activities of approximately $118,000 for the six months ended June 30, 2017. The change is principally a result of the increase in our trade accounts receivable during the 2018 period, partially offset by an increase in net income plus noncash expenses and changes in other components of working capital.

 

Net trade accounts receivable at June 30, 2018 aggregated approximately $9,072,000, an increase of approximately $4,108,000 or 82.8% as compared to approximately $4,964,000 in net trade accounts receivable outstanding at December 31, 2017.  The increase is principally a result of sales during the second quarter of 2018 and a change in payment terms to our largest customer from 30 days to 90 days, which became effective in February 2018. See Note 13 to the condensed consolidated financial statements included in this report for additional information regarding our largest customers. Receivables due from affiliated companies aggregated approximately $888,000 at June 30, 2018, a decrease of approximately $696,000, or 43.9%, from receivables due from affiliated companies of approximately $1,584,000 at December 31, 2017. The decrease reflects payments to us by the affiliated companies during the six months ended June 30, 2018.

 

Inventories, net were approximately $10,134,000 and $9,074,000 at June 30, 2018 and December 31, 2017, respectively, representing an increase of approximately $1,060,000 or 11.7% during the six months ended June 30, 2017. The 2018 increase in inventories reflects anticipated demand for antifreeze products in the third and fourth quarters of 2018.

 

Net cash used in investing activities for the six months ended June 30, 2018 decreased by approximately $1,617,000 or 63.8%, as compared to the six months ended June 30, 2017. Expenditures in both periods are primarily attributable to the expenditures related to the expansion of Kinpak’s manufacturing, warehouse and distribution facilities in Montgomery, Alabama. See “Overview” above for additional information.

  

Net cash provided by financing activities for the six months ended June 30, 2018 was approximately $414,000, as compared to net cash used in financing activities of approximately $781,000 during the six months ended June 30, 2017. The net cash provided by financing activities reflects $1,100,000 of borrowings under our revolving line of credit during the 2018 period; there were no such borrowings in the 2017 period. In both periods, we paid dividends and made payments on long term debt.

 

 17 

 

 

See Notes 6 and 7 to the condensed consolidated financial statements included in this report for information concerning our principal credit facilities, consisting of Kinpak’s obligations relating to an industrial development bond financing, the payment of which we have guaranteed, and a revolving line of credit. At June 30, 2018 and December 31, 2017, we had outstanding balances of approximately $4,343,000 and $4,463,000, respectively, under Kinpak’s obligations relating to the industrial development bond financing, and borrowings of $1,100,000 and $0, respectively, under our revolving credit facility. The loan agreement pertaining to our revolving line of credit, as amended, contains various covenants, including financial covenants requiring a minimum fixed charge coverage ratio (generally, the ratio of (A) EBITDA (as defined in the agreement) for the four most recently completed fiscal quarters minus the sum of Company’s distributions to its shareholders, taxes paid and unfunded capital expenditures during such period to (B) current maturities of Company long-term debt (as defined in the agreement) as of the end of the most recent fiscal quarter plus scheduled interest expense incurred over the most recently completed four fiscal quarters) of 1.20 to 1, tested quarterly, and a maximum “debt to cap” ratio (generally, funded debt divided by the sum of net worth and funded debt) of 0.75 to 1 as of the end of each fiscal quarter. The agreement relating to the revolving line of credit generally defines “long term debt”  as  “debt instruments with a maturity principal due date of one year or more in length,” including, among other listed contractual debt instruments, “revolving lines of credit” and “capital leases obligations.” At June 30, 2018, the Company was in compliance with these financial covenants. Our guarantee of Kinpak’s obligations related to the industrial development bond financing effectively is subject to substantially the same financial covenants.

 

In addition to the industrial development bond financing and the revolving line of credit, we have obtained financing through capital leases for office equipment, totaling approximately $39,000 and $50,000 at June 30, 2018 and December 31, 2017, respectively.

 

The loan agreement pertaining to our revolving line of credit terminates on August 31, 2018. We are engaged in negotiations with our principal lending bank regarding our revolving credit facility, and expect to enter into an agreement with the bank for a renewal or replacement of the existing facility. However, we cannot assure that the negotiations will be successful.

 

Some of our assets and liabilities are denominated in Canadian dollars and are subject to currency exchange rate fluctuations. We do not engage in currency hedging and address currency risk as a pricing issue. For the six months ended June 30, 2018, we recorded $3,844 in foreign currency translation adjustments (decreasing shareholders’ equity by $3,844).

 

During the past few years, we have introduced a number of new products. At times, new product introductions have required us to increase our overall inventory and have resulted in lower inventory turnover rates. The effects of reduced inventory turnover have not been material to our overall operations. We believe that all required capital to maintain such increases will continue to be provided by operations and, if necessary, our current revolving line of credit or a renewal or replacement of the facility. However, as noted above, we cannot assure that we will be able to secure such a renewal or replacement of our revolving line of credit, which expires on August 31, 2018.

 

Many of the raw materials that we use in the manufacturing process are petroleum or chemical based and commodity chemicals that are subject to fluctuating prices. The nature of our business does not enable us to pass through the price increases to our national retailer customers and to our distributors as promptly as we experience increases in raw material costs. This may, at times, adversely affect our margins.

 

We believe that funds provided through operations and our revolving line of credit will be sufficient to satisfy our cash requirements over at least the next twelve months.

 

 18 

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures:

 

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act are (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

 

Change in Internal Controls over Financial Reporting:

 

No change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 1A. Risk Factors

 

In addition to the information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, which could materially affect the Company’s business, financial condition or future results.

 

 19 

 

 

Item 6. Exhibits

 

Exhibit No.   Description
     
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
32.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
32.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
101   The following materials from Ocean Bio-Chem, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017, (ii) Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017, (iii) Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2018 and 2017; (iv) Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 and (v) Notes  to Condensed Consolidated Financial Statements.

 

 20 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the Undersigned thereunto duly authorized.

 

  OCEAN BIO-CHEM, INC.
   
Dated: August 14, 2018 /s/ Peter G. Dornau
  Peter G. Dornau
  Chairman of the Board, President and
  Chief Executive Officer
   
Dated: August 14, 2018 /s/ Jeffrey S. Barocas
  Jeffrey S. Barocas
  Vice President and
  Chief Financial Officer

 

 21